Impact of cancer history on long-term outcome after elective neuro-endovascular treatment in patients aged 80 years or older: A retrospective multicenter observational study.

cancer elder endovascular treatment mortality

Journal

Geriatrics & gerontology international
ISSN: 1447-0594
Titre abrégé: Geriatr Gerontol Int
Pays: Japan
ID NLM: 101135738

Informations de publication

Date de publication:
21 Dec 2023
Historique:
revised: 27 10 2023
received: 27 06 2023
accepted: 05 12 2023
medline: 21 12 2023
pubmed: 21 12 2023
entrez: 21 12 2023
Statut: aheadofprint

Résumé

Assessing the indication for elective neuro-endovascular treatment (EVT) in older patients requires consideration of the impact of systemic comorbidities on their overall reduced life expectancy. The objective of this study was to determine the long-term outcomes of elective neuro-EVT in patients aged ≥80 years, and to investigate the impact of pre-existing cancer on their long-term outcomes. Of the patients enrolled in multicenter observational registry, those aged ≥80 years undergoing elective neuro-EVT between 2011 and 2020 were enrolled. A history of cancer was defined as a pre-existing solid or hematologic malignancy at the time of EVT. The primary outcome was time to death from elective neuro-EVT. Of the 6183 neuro-EVT cases implemented at 10 stroke centers, a total of 289 patients (median age, 82 years [interquartile range 81-84 years]) were analyzed. A total of 58 (20.1%) patients had a history of cancer. A total of 78 patients (27.0%) died during follow up. The 5-year survival rate of enrolled patients was 64.6%. Compared with patients without a history of cancer, those with a history of cancer showed significantly worse survival (log-rank test, P = 0.001). Multivariate Cox proportional hazards analysis showed history of cancer was an independent predictor of time to death from elective neuro-EVT (HR 1.74, 95% CI 1.01-3.00, P = 0.047). Cancer was the leading cause of death, accounting for 25.6% of all deaths. The present study showed that history of cancer has a significant impact on time to death from elective neuro-EVT in patients aged ≥80 years. Geriatr Gerontol Int 2023; ••: ••-••.

Identifiants

pubmed: 38126478
doi: 10.1111/ggi.14784
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023 Japan Geriatrics Society.

Références

Sakai N, Yoshimura S, Taki W et al. Recent trends in neuroendovascular therapy in Japan: analysis of a nationwide survey - Japanese registry of Neuroendovascular therapy (JR-NET) 1 and 2. Neurol Medico-Chirurgica (Tokyo) 2014; 54: 1-8.
Sakai N, Uchida K, Iihara K et al. Japanese surveillance of neuroendovascular therapy in JR-NET - part II. Japanese registry of NeuroEndovascular treatment 3. Main Report Neurol Medico-Chirurgica (Tokyo) 2019; 15: 106-115.
Population projections. EU25 population rises until 2025, then falls; 2005, Available from: https://ec.europa.eu/commission/presscorner/api/files/document/print/en/stat_05_48/STAT_05_48_EN.pdf 2004-2050. accessed 31 March 2023.
Vincent GK, Velkoff VA. The next four decades. The older population in the United States: 2010-50. Population estimates and projections, Available from: https://www.census.gov/content/dam/Census/library/publications/2010/demo/p25-1138.pdf accessed 21 October 2023.
Ministry of internal affairs and communications. Population estimates, 2021. Available from: https://www.stat.go.jp/data/jinsui/2021np/pdf/2021np.pdf [accessed 31 March 2023].
National Institute of Population and Social Security Research. Population projections for Japan, 2017. Available from: https://www.ipss.go.jp/pp-zenkoku/j/zenkoku2017/pp29_ReportALL.pdf [accessed 31 March 2023].
Caffes N, Wenger N, Cannarsa G et al. Unruptured cerebral aneurysms in elderly patients: key challenges and management. Ann Med 2021; 53: 1839-1849.
Laconi E, Marongiu F, DeGregori J. Cancer as a disease of old age: changing mutational and microenvironmental landscapes. Br J Cancer 2020; 122: 943-952.
Ishiwada T, Fujita K, Hirai S et al. Influence of bilateral cerebellar infarction on functional outcome after endovascular treatment for basilar artery occlusion. World Neurosurg 2023; 171: e506-e515.
Khorana AA, Noble S, Lee AYY et al. Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH. J Thromb Haemost 2018; 16: 1891-1894.
Yamamoto M, Adachi H, Enomoto M et al. Lower albumin levels are associated with frailty measures, trace elements, and an inflammation marker in a cross-sectional study in Tanushimaru. Environ Health Prevent Med 2021; 26: 25.
Matsuo S, Imai E, Horio M et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992.
An official website of the European Union. Over 27 million people aged 80 and over in the EU [online]; 2023. Available from: https://ec.europa.eu/eurostat/web/products-eurostat-news/-/EDN-20170930-1 [accessed 31 March 2023].
An official website of the United States government. Actuarial life table [online]; 2023. Available from: https://www.ssa.gov/oact/STATS/table4c6.html [accessed 31 March 2023].
Ministry of Health Labour and Welfare, Japan. Life expectancies at specified ages, 2023. Available from: https://www.mhlw.go.jp/english/database/db-hw/lifetb20/dl/lifetb20-01.pdf [accessed 31 March 2023].
Romain G, Mariet AS, Jooste V et al. Long-term relative survival after stroke: the Dijon stroke registry. Neuroepidemiology 2020; 54: 498-505.
Sorenson TJ, Vine R, Lanzino G. Unruptured intracranial aneurysms in patients over 80 years: natural history and management implications. Acta Neurochirurgica (Wien) 2018; 160: 1773-1777.
Macciò A, Madeddu C, Gramignano G et al. The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study. Haematologica 2015; 100: 124-132.
Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer 2001; 91: 2214-2221.
Zhang Y, Chen Y, Chen D et al. Impact of preoperative anemia on relapse and survival in breast cancer patients. BMC Cancer 2014; 14: 844.
Gibbs J, Cull W, Henderson W, Daley J, Hur K, Khuri SF. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the national VA surgical risk study. Arch Surg 1999; 134: 36-42.
Ministry of Health Labour and Welfare, Japan. Vital statistics, 2022. Available from: https://www.e-stat.go.jp/dbview?sid=0003411659 [accessed 31 March 2023].
Public Health England. Death in people aged 75 years and older in England in 2017, 2019. Available from: https://www.gov.uk/government/publications/death-in-people-aged-75-years-and-older-in-england-in-2017/death-in-people-aged-75-years-and-older-in-england-in-2017 [accessed 31 March 2023].
Heron M. Deaths: leading causes for 2019. Natl Vital Stat Rep 2021; 70: 1-114.

Auteurs

Kyohei Fujita (K)

Department of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan.

Yohei Sato (Y)

Department of Neurosurgery, Japanese Red Cross Musashino Hospital, Tokyo, Japan.

Ryoichi Hanazawa (R)

Department of Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

Hirotaka Sagawa (H)

Department of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan.

Mariko Ishikawa (M)

Department of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan.

Shoko Fujii (S)

Department of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
Department of Neurosurgery, Ome Municipal General Hospital, Tokyo, Japan.

Jiro Aoyama (J)

Department of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan.

Sakyo Hirai (S)

Department of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan.

Masataka Yoshimura (M)

Department of Neurosurgery, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.

Yoshikazu Yoshino (Y)

Department of Neurosurgery, Jichi Medical University Saitama Medical Center, Saitama, Japan.

Yoshihisa Kawano (Y)

Department of Neurosurgery, JA Toride Medical Center, Ibaraki, Japan.

Keigo Shigeta (K)

Department of Neurosurgery, National Hospital Organization Disaster Medical Center, Tokyo, Japan.

Naoki Taira (N)

Department of Neurosurgery, Shuuwa General Hospital, Saitama, Japan.

Jun Karakama (J)

Department of Neurosurgery, Ome Municipal General Hospital, Tokyo, Japan.

Tadahiro Ishiwada (T)

Department of Neurosurgery, Shioda Memorial Hospital, Chiba, Japan.

Motoshige Yamashina (M)

Department of Neurosurgery, Soka Municipal Hospital, Saitama, Japan.

Akihiko Hirakawa (A)

Department of Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

Kazutaka Sumita (K)

Department of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan.

Classifications MeSH